Adaptive immunity in melioidosis: A possible role for T cells in determining outcome of infection with Burkholderia pseudomallei

Clinical Immunology

Volumn 113, Issue 1, 2004, Pages 22-28

  Barnes, J L ^a   Warner, J ^a   Melrose, W ^a   Durrheim, D ^a   Speare, R ^a   Reeder, J C ^b   Ketheesan, N ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

Author keywords

Burkholderia pseudomallei; Cell mediated immunity; Melioidosis; Papua New Guinea; Serology

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE CULTURE; MALE; MELIOIDOSIS; PAPUA NEW GUINEA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; CELL DIVISION; CHILD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; T LYMPHOCYTE;

ADOLESCENT; ADULT; BURKHOLDERIA PSEUDOMALLEI; CELL DIVISION; CHILD; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; MALE; MELIOIDOSIS; MIDDLE AGED; PAPUA NEW GUINEA; T-LYMPHOCYTES;

EID: 6044271225     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.06.006     Document Type: Article

References (42)

1. Leelarasamee A., Bovornkitti S. Melioidosis: review and update. Rev. Infect. Dis. 11:1989;413-425
2. Ashdown L.R., Guard R.W. The prevalence of melioidosis in Northern Queensland. Am. J. Trop. Med. Hyg. 33:1984;474-478
3. Chaowagul W., White N.J., Dance D.A.B., Wattanagoon Y., Naigowit P., Davis T.M., Looareesuwan S., Pitakwatchara N. Melioidosis: a major cause of community-acquired septicemia in Northeastern Thailand. J. Infect. Dis. 159:1989;890-899
4. Currie B.J., Fisher D.A., Howard D.M., Burrow J.N., Selvanayagam S., Snelling P.L., Anstey N.M., Mayo M.J. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop. 74:2000;121-127
5. Newland R.C. Chronic melioidosis: a case in Sydney. Pathology. 1:1969;149
6. Kingston C.W. Chronic or latent melioidosis. Med. J. Aust. 2:1971;618-621
7. Rowlands J.B., Curtis P.G. A case of melioidosis in Papua and New Guinea. Med. J. Aust. ii:1965;494-496
8. DeBuse P.J., Henderson A., White M. Melioidosis in a child in Papua New Guinea: successful treatment with kanamycin and trimethoprim-sulphamethoxazole. Med. J. Aust. 2:1975;476-478
9. Lee L., Naraqui S. Primary gram negative pneumonia in adults in Papua New Guinea. PNG Med. J. 23:1980;174-178
10. Currie B. Melioidosis in Papua New Guinea: is it less common than in tropical Australia? Trans. R. Soc. Trop. Med. Hyg. 87:1993;417
11. Barnes D.J., Gottlieb T., Naraqui S., Benn R. The role of viruses and atypical organisms in the pathogenesis of adult pneumonia in Papua New Guinea. PNG Med. J. 34:1991;13-16
12. Thompson J.E., Ashdown L.R. Melioidosis and latent infection. Med. J. Aust. 151:1989;298-299
13. Warner J., Learoyd D., Pelowa D., Koehler J., Hirst R. Melioidosis in the western province of Papua New Guinea. Medical Society of Papua New Guinea Annual Scientific Meeting, Port Moresby. 1998;38
14. Dorman S.E., Gill V.J., Gallin J.I., Holland S.M. Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin. Infect. Dis. 1998;889-894
15. Egan A.M., Gordon D.L. Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes. Infect. Immun. 64:1996;4952-4959
16. Raupach B., Kaufmann S.H.E. Immune response to intracellular bacteria. Curr. Opin. Immunol. 13:2001;417-428
17. Vorachit M., Lam K., Jayanetra P., Costerton J.W. Electron microscope study of the mode of growth of Pseudomonas pseudomallei in vitro and in vivo. J. Trop. Med. Hyg. 98:1995;379-391
18. Jones A.L., Beveridge T.J., Woods D.E. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:1996;782-790
19. Harley V.S., Dance D.A.B., Tovey G., McCrossan M.V., Drasar B.S. An ultrastructural study of the phagocytosis of Burkholderia pseudomallei. Microbios. 94:1998;35-45
20. Ho M., Schollaardt T., Smith M.D., Perry M.B., Brett P.J., Chaowagul W., Bryan L.E. Specific and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. 65:1997;3648-3653
21. Chaowagul W., Suputtamongkol Y., Dance D.A.B., Rajchanuvong A., Pattara-arechachai J., White N.J. Relapse in melioidosis: incidence and risk factors. J. Infect. Dis. 168:1993;1181-1185
22. Ketheesan N., Barnes J.L., Ulett G.C., Van Gessel H.J., Norton E., Hirst R.G., LaBrooy J.T. Demonstration of a cell-mediated immune response in melioidosis. J. Infect. Dis. 186:2002;286-289
23. Govan B., Ketheesan N. Exposure to Burkholderia pseudomallei induces cell mediated immunity in healthy individuals. Clin. Microbiol. Infect. 2004;. (accepted for publication CLM-03-6008RI; February 2004)
24. Ashdown L.R. Indirect haemagglutination test for melioidosis. Med. J. Aust. 147:1987;364-365
25. Leelarasamee A. Burkholderia pseudomallei: the unbeatable foe? Southeast Asian. J. Trop. Med. Public Health. 29:1998;410-415
26. Currie B.J., Fisher D.A., Howard D.M., Burrow J.N., Lo D., Selvanayagam S., Anstey N.M., Huffam S.E., Snelling P.L., Marks P.J., Stephens D.P., Lum G.D., Jacups S.P., Krause V.L. Endemic melioidosis in tropical Northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 31:2000;981-986
27. Van Phung L., Quynh G.T., Yabuuchi E., Dance D.A.B. Pilot study of exposure to Pseudomonas pseudomallei in Northern Vietnam. Trans. R. Soc. Trop. Med. Hyg. 87:1993;416
28. Naigowit P., Maneeboonyoung W., Wongroonsub P., Chaowagul V., Kanai K. Serosurveillance for Pseudomonas pseudomallei infection in Thailand. Jpn. J. Med. Sci. Biol. 45:1992;215-230
29. Silbermann M.H., Gyssens I.C., Endtz H.P., Kuijper E.J., van der Meer J.T. Two patients with recurrent melioidosis after prolonged antibiotic therapy. Scand. J. Infect. Dis. 29:1997;199-201
30. Inglis T.J., Golledge C.L., Clair A., Harvey J. Case report: recovery from persistent septicemic melioidosis. Am. J. Trop. Med. Hyg. 65:2001;76-82
31. Hou S., Hylaud L., Ryan K., Portner A., Doherty P.C. Virus-specific CD8+ T cell memory determined by clonal burst size. Nature. 369:1994;652-654
32. Busch D.H., Kerksiek K.M., Pamer E.G. Differing roles of inflammation and antigen in T cell proliferation and memory generation. J. Immunol. 164:2000;4063-4070
33. Orme I.M., Anderson P., Boom W.H. T cell responses to Mycobacterium tuberculosis. J. Infect. Dis. 167:1993;1481-1497
34. Surcel H.M., Troye-Blomberg M., Paulie S., Andersson G., Moreno C., Pasvol G., Ivanyi J. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 81:1994;171-176
35. Bosque F., Saravia N.G., Valderrama L., Milon G. Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (viannia) panamensis infection. Scand. J. Immunol. 51:2000;533-541
36. Tufariello J.M., Chan J., Flynn J.L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet, Infect. Dis. 3:2003;578-590
37. Liew F.Y. Regulation of cell-mediated immunity in cutaneous leishmaniasis. Immunol. Lett. 16:1987;321-327
38. Tanphaichitra D., Srimuang S. Cellular immunity (T-cell subset using monoclonal antibody) in tuberculosis, melioidosis, pasteurellosis, penicilliosis; and role of levamisole and Isoprinosine. Dev. Biol. Stand. 57:1983;117-123
39. Ramsay S.C., Ketheesan N., Norton R., Watson A.M., LaBrooy J. Peripheral blood lymphocyte subsets in acute human melioidosis. Eur. J. Clin. Microbiol. Infect. Dis. 21:2002;566-568
40. Santanirand P., Harley V.S., Dance D.A.B., Drasar B.S., Bancroft G.J. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect. Immun. 67:1999;3593-3600
41. Lertmemongkolchai G., Cai G., Hunter C.A., Bancroft G.J. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-γ in response to bacterial pathogens. J. Immunol. 166:2001;1097-1105
42. Murray H.W. Interferon-gamma, the activated macrophage, and host defence against microbial challenge. Ann. Intern. Med. 108:1988;595-608